Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$7,469,811
+$2,134,006 QoQ
Shares Held
20,628
+36.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#655
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $2,298,575,113 across 12 Drug Manufacturers - General names. AMGN ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,979,150 | $1,513,006,423 | |
| 2 | LLY |
ELI LILLY & Co
|
447,654 | $536,929,681 | |
| 3 | JNJ |
Johnson & Johnson
|
691,961 | $175,737,335 | |
| 4 | MRK |
Merck & Co., Inc.
|
207,542 | $26,669,147 | |
| 5 | ABBV |
AbbVie Inc.
|
65,288 | $16,429,072 | |
| 6 | PFE |
Pfizer Inc
|
433,531 | $10,439,426 | |
| 7 | AMGN |
Amgen Inc
This page
|
20,628 | $7,469,811 | |
| 8 | NVS |
Novartis AG
|
43,692 | $6,847,410 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,469,811 | 20,628 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,335,805 | 15,165 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,375,807 | 13,369 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,705,003 | 13,129 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,611,860 | 12,936 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,037,376 | 12,959 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,042,711 | 11,674 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,823,343 | 11,866 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,678,786 | 11,774 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,763,590 | 9,720 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,624,438 | 9,112 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,399,489 | 8,928 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,804,134 | 8,126 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $10,425,710 | 43,126 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,455,964 | 47,426 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,092,255 | 93,577 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,852,666 | 122,699 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $29,937,074 | 123,799 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $26,801,575 | 119,134 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $24,525,775 | 115,334 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $27,796,762 | 114,038 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $24,876,770 | 99,983 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $21,997,825 | 95,676 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $21,998,818 | 86,555 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $19,861,770 | 84,210 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $15,739,551 | 77,638 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||